Movia Robotics launched its TheraPal line of digital health aides for autism and other intellectual or developmental disabilities.
Bristol, Connecticut-based Movia Robotics released its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assist aides for use in homes and clinician offices. The Robot-Assisted Intervention (RAI) aides are designed to be used by parents, therapists and other healthcare professionals for the development and learning of individuals with neurodevelopmental or intellectual challenges, according to the company.
“We are focused on showing how robotics can improve the lives of individuals with autism and other special needs, and the launch of our TheraPal is the first step in our commitment to FDA digital health certification,” says MOVIA Robotics CEO, Jean-Pierre Bolat.
The TheraPal product line, powered by MOVIA’s proprietary software, assists neuro-diverse children with their Individualized Treatment Plan goals while providing metrics for assessment in every module. The TheraPal Progress Tracker is a medical device data system that is utilized as an assist tool for both the homecare individuals (including educators, consumer caregivers and parents) and clinicians to collect data during sessions with the robots to be used by therapists and other clinicians to monitor and assess an individual’s progress. The collected data will be used for visualization and information purposes.
With metrics on assessment objectives including verbalization, interpersonal coordination, reaction time, and gross or fine motor skills, MOVIA’s TheraPal provides assessments of an individual’s progress, free of social judgement, human error, or bias. The TheraPal Progress Tracker’slaunch introduces a medical device into the child’s ecosystem that empowers clinicians and caregivers to integrate and better assess data about a child’s progress.